Vanguard Group Inc Arrowhead Pharmaceuticals, Inc. Transaction History

Vanguard Group Inc

$6.44 Trillion
Q3 2025

A detailed history of Vanguard Group Inc transactions in Arrowhead Pharmaceuticals, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 16,035,870 shares of ARWR stock, worth $662 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

16,035,870

Previous 15,525,072 3.29%

Holding current value

$662 Million

Previous $245 Million 125.47%

% of portfolio

0.01%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 07, 2025	BUY	$14.71 - $34.49 $7.51 Million - $17.6 Million	510,798 Added 3.29%	16,035,870 $553 Million
Q2 2025 Aug 11, 2025	BUY	$9.99 - $16.97 $23.2 Million - $39.4 Million	2,322,510 Added 17.59%	15,525,072 $245 Million
Q1 2025 May 09, 2025	BUY	$12.74 - $21.53 $13 Million - $21.9 Million	1,018,273 Added 8.36%	13,202,562 $168 Million
Q4 2024 Feb 11, 2025	SELL	$17.7 - $26.34 $792,358 - $1.18 Million	-44,766 Reduced 0.37%	12,184,289 $229 Million
Q3 2024 Nov 13, 2024	BUY	$19.36 - $29.54 $289,509 - $441,741	14,954 Added 0.12%	12,229,055 $237 Million

Q2 2024 Aug 13, 2024	SELL	$21.87 - $28.24 $4.15 Million - $5.36 Million	-189,949 Reduced 1.53%	12,214,101 $317 Million
Q1 2024 May 10, 2024	BUY	$27.21 - $39.48 $47.1 Million - $68.4 Million	1,731,974 Added 16.23%	12,404,050 $355 Million
Q4 2023 Feb 14, 2024	SELL	$21.2 - $31.03 $3.95 Million - $5.78 Million	-186,239 Reduced 1.72%	10,672,076 $327 Million
Q3 2023 Nov 14, 2023	SELL	$26.2 - $36.08 $2.97 Million - $4.09 Million	-113,415 Reduced 1.03%	10,858,315 $292 Million
Q2 2023 Aug 14, 2023	BUY	$25.16 - $41.38 $7.14 Million - $11.7 Million	283,859 Added 2.66%	10,971,730 $391 Million
Q1 2023 May 15, 2023	BUY	$23.68 - $38.51 $9.51 Million - $15.5 Million	401,699 Added 3.91%	10,687,871 $271 Million
Q4 2022 Feb 10, 2023	BUY	$28.0 - $40.56 $3.93 Million - $5.69 Million	140,182 Added 1.38%	10,286,172 $417 Million
Q3 2022 Nov 14, 2022	BUY	$29.63 - $48.31 $2.27 Million - $3.7 Million	76,653 Added 0.76%	10,145,990 $335 Million
Q2 2022 Aug 12, 2022	BUY	$27.79 - $50.61 $9.76 Million - $17.8 Million	351,087 Added 3.61%	10,069,337 $355 Million
Q1 2022 May 13, 2022	BUY	$39.62 - $69.97 $3.09 Million - $5.47 Million	78,107 Added 0.81%	9,718,250 $447 Million
Q4 2021 Feb 14, 2022	SELL	$58.09 - $82.51 $219,173 - $311,310	-3,773 Reduced 0.04%	9,640,143 $639 Million
Q3 2021 Nov 12, 2021	BUY	$58.38 - $84.96 $283,259 - $412,225	4,852 Added 0.05%	9,643,916 $602 Million
Q2 2021 Aug 13, 2021	BUY	$62.15 - $90.32 $599 Million - $871 Million	9,639,064 New	9,639,064 $798 Million

Others Institutions Holding ARWR

# of Institutions

339

Shares Held

103M

Call Options Held

953K

Put Options Held

263K

View Full List

About ARROWHEAD PHARMACEUTICALS, INC.

Ticker ARWR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,849,000
Market Cap $4.37B
Description
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...

More about ARWR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Account

Vanguard Group Inc Arrowhead Pharmaceuticals, Inc. Transaction History